Journal article
Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
Authors
Fu S; Hirte H; Welch S; Ilenchuk TT; Lutes T; Rice C; Fields N; Nemet A; Dugourd D; Piha-Paul S
Journal
Investigational New Drugs, Vol. 35, No. 3, pp. 397–397
Publisher
Springer Nature
Publication Date
June 1, 2017
DOI
10.1007/s10637-017-0455-y
ISSN
0167-6997